Vitamin e supplementation in cystic fibrosis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 25, Issue 1, 1997, Pages 120-121

  Winklhofer Roob, Brigitte M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; CYSTIC FIBROSIS; DOSE RESPONSE; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT INDICATION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

CYSTIC FIBROSIS; HUMANS; VITAMIN E;

EID: 0030738717     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-199707000-00028     Document Type: Letter

References (12)

1. Peters SA, Kelly FJ. Vitamin E supplementation in cystic fibrosis. J Pediatr Gastroenterol Nutr 1996;22:341-5.
2. Ramsey BW, Farrell PM, Pencharz P, and the Consensus Committee. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992;55:108-16.
3. Horwitt MK. The term α-tocopherol should not be used without clarification [Letter]. Am J Clin Nutr 1991;54:760-70.
4. Traber MG. Determinants of plasma vitamin E concentrations. Free Radic Biol Med 1994;16:229-39.
5. Winklhofer-Roob BM, Tuchschmid PE, Molinari L, Shmerling DH. Response to a single oral dose of all-rac-α-tocopheryl acetate in patients with cystic fibrosis and healthy individuals. Am J Clin Nutr 1996;63:717-21.
6. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 1986;23:514-20.
7. Winklhofer-Roob BM, Shmerling DH, Schimek MG, Tuchschmid PE. Short-term changes in erythrocyte alpha-tocopherol content of vitamin E deficient patients with cystic fibrosis. Am J Clin Nutr 1992;55:100-3.
8. Lehmann J. Comparative sensitivities of tocopherol levels of platelets, red blood cells, and plasma for estimating vitamin E nutritional status in the rat. Am J Clin Nutr 1981;34:2104-10.
9. Winklhofer-Roob BM, Van't Hof MA, Shmerling DH. Long-term oral vitamin E supplementation in cystic fibrosis: RRR-α-tocopherol versus all-rac-α-tocopheryl acetate. Am J Clin Nutr 1996;63:722-8.
10. Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Paediatr 1994;suppl 395:49-57.
11. Winklhofer-Roob BM, Ziouzenkova O, Puhl H, Ellemunter H, Greiner P, Müller G, Van't Hof MA, Esterbauer H, Shmerling DH. Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Free Radic Biol Med 1995;19:725-33.
12. Winklhofer-Roob BM, Ziouzenkova O, Gollner K, Khoschsorur G, Ellemunter H, Esterbauer H, Shmerling DH. Effect of oral vitamin E supplementation on lipid peroxidation in cystic fibrosis [Abstract]. Pediatr Pulmonol 1994;suppl 10:281.